Active hexose-correlated compound enhances extrinsic-pathway-mediated apoptosis of Acute Myeloid Leukemic cells

MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome

(2016) Vaia Stavropoulou et al.   CANCER CELL

Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma

(2016) Hiroaki Yanagimoto et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Introduction to the review series on advances in acute myeloid leukemia (AML)

(2015) B. Lowenberg et al.   BLOOD

Current challenges in clinical development of "targeted therapies": the case of acute myeloid leukemia

(2015) E. Estey et al.   BLOOD

Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia

(2015) B. J. Wouters et al.   BLOOD

An update of current treatments for adult acute myeloid leukemia

(2015) H. Dombret et al.   BLOOD

Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model

(2015) Rosa Mistica Ignacio et al.   CYTOKINE

Active Hexose Correlated Compound (AHCC) promotes an intestinal immune response in BALB/c mice and in primary intestinal epithelial cell culture involving toll-like receptors TLR-2 and TLR-4

(2015) Jean-François Mallet et al.   EUROPEAN JOURNAL OF NUTRITION

Acute Myeloid Leukemia

(2015) Hartmut Döhner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Active hexose correlated compound potentiates the antitumor effects of low-dose 5-fluorouracil through modulation of immune function in hepatoma 22 tumor-bearing mice

(2015) Zhiyun Cao et al.   Nutrition Research and Practice

Reduction of Adverse Effects by a Mushroom Product, Active Hexose Correlated Compound (AHCC) in Patients With Advanced Cancer During Chemotherapy—The Significance of the Levels of HHV-6 DNA in Saliva as a Surrogate Biomarker During Chemotherapy

(2014) Toshinori Ito et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Clinical Results of Hypomethylating Agents in AML Treatment

(2014) Marjan Cruijsen et al.   Journal of Clinical Medicine

How does the metabolism of tumour cells differ from that of normal cells

(2013) Nívea Dias Amoêdo et al.   BIOSCIENCE REPORTS

Effect of Active Hexose-Correlated Compound in Women Receiving Adjuvant Chemotherapy for Breast Cancer: A Retrospective Study

(2013) Sho Hangai et al.   JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE

Toll-like Receptor 2 Ligands Regulate Monocyte Fcγ Receptor Expression and Function

(2013) Prexy Shah et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Acute myeloid leukaemia in adults

(2013) Felicetto Ferrara et al.   LANCET

Caspase Functions in Cell Death and Disease

(2013) D. R. McIlwain et al.   Cold Spring Harbor Perspectives in Biology

Active Hexose Correlated Compound promotes T helper (Th) 17 and 1 cell responses via inducing IL-1β production from monocytes in humans

(2012) Won-Woo Lee et al.   CELLULAR IMMUNOLOGY

The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-κB/MAPK activation

(2012) Abdelali Daddaoua et al.   FOOD CHEMISTRY

Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia

(2012) Krzysztof Mrózek et al.   JOURNAL OF CLINICAL ONCOLOGY

Reciprocal Regulation of Activating and Inhibitory Fc  Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy

(2010) J. P. Butchar et al.   CLINICAL CANCER RESEARCH

Selective FLT3 inhibitor FI-700 neutralizes Mcl-1 and enhances p53-mediated apoptosis in AML cells with activating mutations of FLT3 through Mcl-1/Noxa axis

(2009) K Kojima et al.   LEUKEMIA

Reconstitution of the Death-Inducing Signaling Complex Reveals a Substrate Switch that Determines CD95-Mediated Death or Survival

(2009) Michelle A. Hughes et al.   MOLECULAR CELL

Active hexose correlated compound activates immune function to decrease bacterial load in a murine model of intramuscular infection

(2008) Hernan Aviles et al.   AMERICAN JOURNAL OF SURGERY